Td Asset Management Inc Atea Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$5.33 - $8.18 $271,046 - $415,977	-50,853 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$7.67 - $44.59 $319,179 - $1.86 Million	-41,614 Reduced 45.0%	50,853 $455,000
Q2 2021 Aug 11, 2021	BUY	$19.22 - $59.08 $1.3 Million - $3.99 Million	67,482 Added 270.09%	92,467 $2.32 Million
Q1 2021 May 14, 2021	BUY	$41.42 - $88.44 $178,023 - $380,115	4,298 Added 20.78%	24,985 $1.54 Million
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $545,309 - $864,302	20,687 New	20,687 $864,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $281M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.